×
Hero Background

Asperger Syndrome Companies

ID: MRFR/Pharma/4383-HCR
100 Pages
Rahul Gotadki
October 2025

Asperger's Syndrome is no longer officially recognized as a separate diagnosis from Autism Spectrum Disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). However, individuals who were previously diagnosed with Asperger's Syndrome are often still identified as having traits associated with high-functioning autism within the broader spectrum.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Asperger Syndrome Market Research Report - Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Asperger Syndrome Market

Asperger

 


Latest Asperger Syndrome Companies Updates:


Akili Interactive Labs receives FDA approval for EndeavorRx This video game-based therapy received approval for improving attention function in children with ASD aged 8-12 years old. This marks a significant advancement in using digital therapeutics for ASD intervention.


Studies on AI-powered tools Companies are actively researching AI-powered tools to analyze language, facial expressions, and eye movements for early detection of ASD in children. Early detection and intervention is crucial for improving long-term outcomes.


List of Asperger Syndrome Key companies in the market:



  • Eli Lilly and company

  • Shire

  • Jazz Pharmaceuticals

  • Pfizer

  • GlaxoSmithKline

  • Forest laboratories

  • Johnson & Johnson

  • Bristol-Myers Squibb

  • Otsuka pharmaceutical

  • AstraZeneca